• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    Recently Awarded NIH Grants

    April 2015 | eNews The NIH continues to recognize DF/HCC as a leader in cancer research by awarding funding to a number of our research initiatives. Recently, this... | [more]

    Erlotinib with a PDL-1 Inhibitor in Advanced NSCLC

    April 2015 | eNews Rebecca Heist, MD (MGH) and colleagues are conducting a Phase Ib study to evaluate the safety and efficacy of the PD-L1 inhibitor MDPL3280A combined... | [more]

    Cancer Epidemiology Goes “Omic”

    April 2015 | eNewsEpidemiology—the study of disease conditions and risk factors within defined populations—as with other branches of medicine, is becoming ever more... | [more]